Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) for the reporting period ending October 24, 2002. The filing reports the sale of its wholly owned subsidiary, Dock Res Corporation, to The Lubrizol Corporation.
Key Financial Metrics
- Sale Price: $13,500,000 in cash (subject to post-closing working capital adjustments).
- Escrow Amount: $1,350,000 held until January 31, 2004, for indemnification purposes.
- Estimated Loss on Sale: $1.7 million to be recognized in fiscal year 2002.
- Historical Loss: $2.5 million previously recognized in fiscal year 2001 upon approval of the sale plan.
- Insurance Claim: Rights to claims from a February 2000 fire were assigned to Landec; no gain recorded as the benefit cannot be reasonably estimated.
Material Changes
The primary material change is the disposition of Dock Resins Corporation, a developer and manufacturer of proprietary polymers. Consequently, Dock's financial results are classified as a discontinued operation, and its net assets are reflected as assets held for sale. The transaction includes a three-year supply agreement where Landec will purchase specific polymer products from Dock at cost plus a reasonable margin.
Outlook, Risks, and Contingencies
- Working Capital Adjustment: The final purchase price is contingent on the net working capital of Dock as of the closing date compared to the April 2002 balance sheet.
- Pro Forma Information: Unaudited pro forma financial statements are provided in Exhibit 99.1, assuming the disposition occurred on prior dates (October 30, 2000, and October 29, 2001). These do not project future results.
- Contingency: The $1.35 million escrow serves as a contingency for potential breaches of representations or warranties.
Investor Verification Checklist
- Verify the final net working capital adjustment to determine the actual cash proceeds received.
- Review the Unaudited Pro Forma Consolidated Financial Statements in Exhibit 99.1 to understand the impact of the discontinued operation on historical results.
- Confirm the terms of the three-year supply agreement to assess future cost structures for polymer products.
- Monitor the status of the insurance claim regarding the 2000 fire for any potential future gain recognition.